Updated on 1 October 2026
Request of funding and linking
Senior innovation consultant at PNO Innovation srl
Milano, Italy
About
PNO Innovation Srl is a leading European innovation consulting company supporting research organisations, companies, healthcare institutions, and public authorities in designing and delivering high-impact R&I projects. Within the Horizon Europe Mission Cancer framework, PNO offers strategic, technical, and operational expertise to strengthen collaborative research addressing cancer prevention, early detection, diagnostics, treatment, survivorship, and patient-centred care.
PNO Innovation combines deep domain knowledge in biomedical research, digital health, personalised medicine, AI-enabled healthcare solutions, data governance, and translational innovation. Our experts support beneficiaries in shaping robust project concepts, building interdisciplinary consortia, developing evidence-based intervention strategies, and defining impactful exploitation, dissemination, and communication plans aligned with Mission Cancer objectives.
We provide strong capabilities in stakeholder mapping, patient engagement, policy and ecosystem analysis, market assessment, and innovation management. PNO ensures that research outcomes are translated into sustainable value through tailored exploitation pathways, business modelling, regulatory roadmaps, and clinical innovation strategies.
A key asset is PNO’s Linking Service, a structured process that matches project needs with complementary partners, technologies, infrastructures, and funding opportunities across Europe. This service facilitates high-quality collaborations and maximises the project’s reach, coherence, and long-term impact.
PNO Innovation brings a proven track record across EU health programmes, offering end-to-end support— from proposal design to project implementation and reporting —ensuring excellence, societal relevance, and measurable progress toward the Mission Cancer targets.
Similar opportunities
Product
Licensing Opportunity: Explainable Breast-Cancer Prognosis with Coherent Voting Networks
Marco Pellegrini
Director of Research at Consiglio Nazionale delle Ricerche
Pisa, Italy
Project cooperation
Open to project cooperation activities
Luca Falzone
Associate Professor at BIOMETEC Dept - university of Catania
Catania, Italy
Investment
PETsign - A PET-surrogate multigene signature for breast cancer prognosis
- Pre-seed funding | Idea validation
- Seed funding | Get business started
Giorgia Moschetti
IP & Technology Transfer Specialist at Istituto Europeo di Oncologia (IEO)
Milan, Italy